Online ISSN: 2582-5062
Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...Review Article
Author Details :
Volume : 6, Issue : 3, Year : 2024
Article Page : 68-72
https://doi.org/10.18231/j.ctppc.2024.019
Abstract
CRISPR-Cas9 technology has rapidly evolved and expanded its applications since its inception in 2015. This research paper provides a comprehensive overview of the advancements and applications of CRISPR-Cas9 technology from 2015 to 2023. We review key milestones in CRISPR-Cas9 research, including improvements in genome editing efficiency, novel applications in gene therapy and biotechnology, and emerging trends in CRISPR-based diagnostics and therapeutics. Additionally, we discuss the ethical considerations, regulatory challenges, and future prospects of CRISPR-Cas9 technology. Through a thorough analysis of the literature spanning nearly a decade, this paper aims to highlight the transformative impact of CRISPR-Cas9 technology on biomedical research and its potential for addressing pressing societal challenges.
Keywords: CRISPR-Cas9, Genome editing, Gene therapy, Biotechnology, Diagnostics, Regulatory challenges
How to cite : Nerkar A G, Banginwar Y, Dawande A, Evolution and applications of CRISPR-Cas9 technology in last decade. Curr Trends Pharm Pharm Chem 2024;6(3):68-72
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.